MPH MITTELSTAENDISCHE PHARMA HOLDING AG March 31, 2015
MPH Mittelständische Pharma Holding AG: Announcement of the purchase of the majority of the equity of the company CR Capital Real Estate, Berlin.The company MPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0L1H32), announces the purchase of the majority of the equity of the company CR Capital Real Estate AG, Berlin (ISIN: DE000A0WMQ53).
Already in 2014 we used the attractive pricing of the share, according to our assessment, for an acquisition above the level of 25%. The value and price of the investment developed very positive and motivated us to further increase the holding. MPH owns now more than 50% of the shares. We see further potential for
CR Capital Real Estate AG, especially in the segment of healthcare properties, which provide attractive value development with independence from economic cycles.
About MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on the growth markets Pharma and
Healthcare. The pharmaceutical sector makes a contribution towards cutting costs in the healthcare system with medicines manufactured on the basis of patent-free and
patent-protected active substances for the therapy of chronic diseases. The field of healthcare offers healthcare preparations, individual patient therapies, aesthetic surgeries and other medical treatments.
Key figures for the share of MPH Mittelständische Pharma Holding AG: Subscribed capital: EUR 42,813,842
Listed shares: ordinary shares
ISIN: DE000A0L1H32
WKN: A0L1H3
Stock symbol: 93M
MPH Mittelständische Pharma Holding AG Fasanenstraße 77
D-10623 Berlin
Phone:+49 (0) 30 897308660 Fax:+49 (0) 30 897308669
E-Mail: ir@mph-ag.deWeb: www.mph-ag.de
MPH Mittelständische Pharma Holding AG Patricia Blechinger
Hubertusallee 73 Tel.: +49 (0) 30 897 30 86 60 E-Mail: ir@mph-ag.de
D-14193 Berlin Fax: +49 (0) 30 897 30 86 70 Web: www.mph-ag.de
|
distributed by
|
